Anthony R. Chase, Director at AVI BIOPHARMA INC (AVII), bought 29,607 shares at $1.41 ($42K) on 2010-05-17, disclosed to the SEC on 2010-05-18.
Open-market purchase of $42k AVII by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.41 | 18,539 | $26K | 62.1% |
| 2 | $1.41 | 500 | $705 | 1.7% |
| 3 | $1.44 | 10,568 | $15K | 36.2% |
| Total | $1.42 avg | 29,607 | $42K | 100% |
| Filing → |
| LYB | BUY | 2023-07-10 | $3K | — | Filing → |
| APC | BUY | 2017-05-18 | $200K | — | Filing → |
| APC | BUY | 2014-09-02 | $189K | — | Filing → |